Loading company…
reverSASP Therapeutics develops drugs for diseases related to aging and senescent cells.
Founded in 2022 and based in Tokyo, reverSASP Therapeutics researches drugs for aging-related diseases, focusing on inflammatory senescent cells. In July 2022, it raised seed funding from Fast Track Initiative and UTokyo Innovation Platform to support its business operations.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in